# Il-Yang Pharmaceutical

Source: https://onco.cc/companies/il-yang-pharmaceutical/  
OnCo record `il-yang-pharmaceutical` (Company). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)"; commercial use needs a licence.

## TL;DR

Il-Yang Pharmaceutical is a South Korea-based pharmaceutical company that leads 2 cancer trials in OnCo, testing the BCR-ABL inhibitor radotinib (Supect) in chronic myeloid leukaemia.

## Summary

Il-Yang Pharmaceutical is a South Korean pharmaceutical manufacturer founded in 1946 that produces prescription and over-the-counter medicines, influenza vaccines and health products. Its in-house new drugs include Noltec (ilaprazole) and Supect (radotinib), a BCR-ABL tyrosine kinase inhibitor for chronic myeloid leukaemia. On ClinicalTrials.gov it is the lead sponsor of 2 trials recorded in OnCo (2 in phase 3 or 2/3): NCT03459534 (phase 3, A Phase 3 Study for the Efficacy and Safety of Radotinib in CP-CML Patients With Failur...) and NCT03722420 (phase 3, Randomized Evaluation of Radotinib Versus Imatinib in Phase III Study for Efficacy With...). Sponsor and trial facts are from the ClinicalTrials.gov registry; company facts are from the official website.

## Fields

- Kind: Company
- Last checked: 2026-09-17
- Also known as: Il-Yang Pharm; Ilyang; 일양약품
- Tags: ctgov-sponsor
- HQ: Yongin
- Type: pharma
- Website: https://www.ilyang.co.kr
- Ticker: KRX:007570

## Sources

- Official website: https://www.ilyang.co.kr
- ClinicalTrials.gov: trials led by Il-Yang Pharmaceutical: https://clinicaltrials.gov/search?lead=Il-Yang%20Pharm.%20Co.%2C%20Ltd.

## Connected records

- cancers: [Chronic myeloid leukaemia (CML)](https://onco.cc/cancers/cml/)
- drugs: [Imatinib](https://onco.cc/drugs/imatinib/), [Radotinib](https://onco.cc/drugs/radotinib/)
- trials: [A Phase 3 Study for the Efficacy and Safety of Radotinib in CP-CML Patients With Failure or Intolerance to Previous TKIs](https://onco.cc/trials/nct03459534/), [Randomized Evaluation of Radotinib Versus Imatinib in Phase III Study for Efficacy With Chinese Patients (RERISE China)](https://onco.cc/trials/nct03722420/)

---
JSON: https://onco.cc/api/v1/entities/il-yang-pharmaceutical.json